"In 2022, J&J made $17.9 billion in profits, and its CEO received $27.6 million in compensation. That year, the company spent $17.8 billion on stock buybacks, dividends, and executive compensation, while the company spent just $14.6 billion on R&D, the report states. "In other words, the company spent $3.2 billion more enriching executives and stockholders than finding new cures," it concludes.
In 2022, Bristol Myers Squibb also spent $3.2 billion more on stock buybacks, dividends, and executive compensation than R&D—$12.7 billion on executives and stockholders compared with $9.5 billion on R&D. That year, the company made $6.3 billion in profits, and its former CEO made $41.4 million in compensation."
It's pretty clear where these corporations' priorities lie. I wonder how much of their R&D was funded by US taxpayers.
Yes it literally is. Or at the very least you have to "submit yourself to a higher power"